Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $365
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter maintains an Equal-Weight rating on HCA Healthcare (NYSE:HCA) and raises the price target from $315 to $365.
July 30, 2024 | 12:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Stephen Baxter maintains an Equal-Weight rating on HCA Healthcare and raises the price target from $315 to $365.
The raised price target from $315 to $365 by Wells Fargo indicates a positive outlook on HCA Healthcare's future performance, which is likely to have a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100